Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
University of California, San Francisco
Ohio State University Comprehensive Cancer Center
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Mayo Clinic
University of Washington
Mayo Clinic
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center